SEC Filing Update: #INBX Inhibrx Biosciences, Inc. : $88.37

Sector: Healthcare | YTD: 🔼+ 18.05% The SEC disclosed Today (14-AUG-2026) that PERCEPTIVE ADVISORS LLC has INCREASED #INBX Shares by 14.77% 🟢 SCHONFELD STRATEGIC ADVISORS LL also reported an increase in its holdings on the same day. VIKING GLOBAL INVESTORS LP also reported an increase in its holdings on the same day. * Previous Holdings: 1.30M Shares * Current Holdings: 1.49M Shares * Increase+191.68K * Increased(%)+14.77% * Ownership: 9.99% * Estimated Investment Value: $17.15M https://www.thinksabio.com/reports/isr/INBX The quarterly average prices of #INBX: Q3 2025: $24.62 Q4 2025: $67.95 Q1 2026: $74.17 📌 Institutional activity in the last 30 days for #INBX: • BANK OF AMERICA CORP DE – Increased holdings by 824,635 shares (03-AUG-2026) • SCHONFELD STRATEGIC ADVISORS LL – Increased holdings by 84,092 shares (14-AUG-2026) • VIKING GLOBAL INVESTORS LP – Increased holdings by 259,692 shares (14-AUG-2026)